Response of diabetic papillopathy to intravitreal bevacizumab
MEAJO-Middle East African Journal of Ophthalmology. 2011; 18 (3): 243-245
em Inglês
| IMEMR
| ID: emr-130064
ABSTRACT
Diabetic papillopathy is an uncommon hyperemic optic disc swelling that occurs in patients with long-standing diabetes, is typically self-resolving with minimal effect on vision, and is likely ischemic in origin. The purpose of the current report is to document the response of diabetic papillopathy to intravitreal injection of bevacizumab [Avastin, Genentech Inc, San Francisco, California, USA], a humanized monoclonal antibody to vascular endothelial growth factor
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Corpo Vítreo
/
Resultado do Tratamento
/
Inibidores da Angiogênese
/
Fator A de Crescimento do Endotélio Vascular
/
Retinopatia Diabética
/
Injeções
/
Anticorpos Monoclonais
Tipo de estudo:
Relato de Casos
Limite:
Adulto
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Middle East Afr. J. Ophthalmol.
Ano de publicação:
2011
Similares
MEDLINE
...
LILACS
LIS